accounttimes consensus 2010 earnings, more than double the P/E ratios of the company's main diabetes care rivals Eli Lilly (LLY.N) and Sanofi-Aventis (SASY.PA). For more double click on [ID:nLDE60S1EN] [ID:nLDE5BK0R6] Reuters Messaging...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to STOCKS NEWS EUROPE-Novo Nordisk up near all-time high
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account